Just diagnosed with Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13)?
You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13), look for clinical trials, and connect with others living with it — all in one place.
Open the full interactive Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13) hub →Overview
Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13) is a rare condition. Also known as Megakaryoblastic AML with t(1;22)(p13;q13). Tomeko brings together the specialists, research, clinical trials, treatments and community for Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13) so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:402023 · ICD-10 C94.2 · GARD 0021712
Find care for Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13)
- Find a specialist or center for Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13)
- Search recruiting clinical trials for Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13)
- Open the interactive Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13) hub — care near you, live trials & community
Authoritative references for Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13)
Research & market landscape for Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13)
Following Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13) for research or industry? Tomeko brings together the recruiting trials, the latest literature, patient organizations, and the specialist and care-center footprint for Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13) — the real-world landscape behind the condition, in one place.
- Latest Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13) research on PubMed ↗
- Recruiting Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13) trials on ClinicalTrials.gov ↗
- Explore the Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13) research & specialist footprint on Tomeko
Researchers, patient organizations & industry: Tomeko provides de-identified, no-PHI demand and engagement signal, trial awareness, and a labeled, editorially-firewalled presence for Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13) and every rare condition. See how Tomeko works with industry →
Common questions
What is Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13)?
Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13) is a rare condition. Also known as Megakaryoblastic AML with t(1;22)(p13;q13). For an authoritative medical description see the reference sources on this page; Tomeko brings the specialists, clinical trials, patient organizations and community for Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13) together in one place.
What are the symptoms of Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13)?
Symptoms of Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13) vary from person to person. For a reviewed, plain-language overview see the authoritative references below (NIH GARD, Orphanet), and discuss your own symptoms with a clinician who treats Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13).
How is Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13) treated?
Treatment for Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13) depends on the individual and is managed by specialists. Use Tomeko to find clinicians and Centers of Excellence who see Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13), and review current options with them.
What causes Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13) — is it genetic?
The cause and inheritance of Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13) are described in the authoritative references linked on this page. A genetics or specialist clinician who treats Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13) can explain what it means for you and your family.
I was just diagnosed with Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13) — what should I do first?
Start by learning the basics from an authoritative source, find a specialist or center that sees Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13), and connect with a patient organization. Tomeko brings these together on one hub.
Where can I find a specialist for Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13)?
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13), filtered to your area.
Are there clinical trials for Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13)?
Tomeko shows live, recruiting studies for Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13) from ClinicalTrials.gov on the hub.
Related conditions
Other conditions on Tomeko you may be looking for: